Nissan on Tuesday named chief planning officer Ivan Espinosa to take the helm from April 1, marking the end to weeks of speculation over who would succeed Makoto Uchida as leader of the troubled ...

The rumors flying last week that Nissan CEO Makoto Uchida had one foot out the door have come true. On Tuesday, the Yokohama, Japan-based automaker announced the resignation of Uchida in the same ...

Nissan said Tuesday that Ivan Espinosa, its chief planning officer, would take the helm from April 1, ending weeks of speculation over who will succeed Makoto Uchida as leader of the troubled ...

Bad Bunny is never leaving Puerto Rico. To celebrate his 31st birthday, the reggaeton star shared the video for “La Mudanza,” which stresses his eternal love for his native island and his ...

While acting as VP of global strategy, Espinosa said it was his dream to build a new version of the Nissan Silvia. "It’ll be a challenge," he said at the time. "But it’s my job to find ways to ...

SpaceX's previous rocket launches were captured flying across San Diego County skies. Just a few hours before the planned launch on Saturday, the decision was made to stand down from the mission ...

GameSpot may get a commission from retail offers. Developer Psyonix has announced a futuristic theme for Rocket League Season 18, with this new season kicking off on March 14. The season brings a ...

It drives by itself, detecting obstacles, stopping for pedestrians and changing lanes without human input. Carmaker Nissan has unveiled its latest self-driving technology, part of Japan’s push towards ...

Rocket Cos. is pushing deeper into the property market with a deal to buy Redfin Corp. that values the real estate listing site at $1.75 billion. The Detroit-based financial technology group will ...

The payload is the next batch of SpaceX's Starlink internet satellites. As it flies into the night sky, the rocket will travel southeast from the launch pad. When is the next launch? Is there a ...

Amgen’s $400 million eczema drug candidate has recorded two more phase 3 victories. The data drops provide more evidence that the Kyowa Kirin-partnered rocatinlimab improves outcomes in atopic ...